Hillstream BioPharma has a total of 28 patents globally, out of which 4 have been granted. Of these 28 patents, more than 85% patents are active. The United States of America is where Hillstream BioPharma has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also United Kingdom is the origin country of Hillstream BioPharma.
Hillstream BioPharma was founded in 2017. The company Hillstream BioPharma is in the biotechnology industry. The company creates brand-new therapeutic candidates that target ferroptosis, a recently discovered anti-cancer mechanism that causes iron-mediated cell death (IMCD) in the case of tumours that are resistant to treatment. International clients are served by Hillstream BioPharma.
Do read about some of the most popular patents of Hillstream BioPharma which have been covered by us in this article and also you can find Hillstream BioPharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Hillstream BioPharma patent portfolio.
How many patents do the Founder and CEO of Hillstream BioPharma have?
The Founder and CEO Randy Milby have 13 patents.
How many patents does Hillstream BioPharma have?
Hillstream BioPharma has a total of 28 patents globally. These patents belong to 11 unique patent families. Out of 28 patents, 24 patents are active.
How Many Patents did Hillstream BioPharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Hillstream BioPharma Applications Filed | Hillstream BioPharma Patents Granted |
| 2022 | 5 | 2 |
| 2021 | 8 | – |
| 2019 | 5 | 1 |
| 2018 | 7 | 1 |
| 2017 | 1 | – |
| 2016 | 1 | – |
| 2013 | 1 | – |
How many Hillstream BioPharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Hillstream BioPharma File in Different Countries?
Countries in which Hillstream BioPharma Filed Patents
| Country | Patent |
| United States Of America | 9 |
| Australia | 3 |
| Canada | 3 |
| Europe | 3 |
| Hong Kong (S.A.R.) | 2 |
| China | 2 |
Where are Research Centers of Hillstream BioPharma Patents Located?
List of Hillstream BioPharma patents
| Hillstream BioPharma Patent | Title |
| US11484507B2 | Polymeric Nanoparticles Providing Nucleic Acids Encoding Tnf-Α |
| US11246904B2 | Polymeric Nanoparticles And A Process Of Preparation Thereof |
| US10364253B2 | Salinomycin Derivatives And Therapeutic Uses Thereof |
| US10092617B2 | Polymeric Nanoparticles And A Process Of Preparation Thereof |
| US20230157969A1 | Polymeric Nanoparticles Providing Nucleic Acids Encoding Tnf-A |
| US20220175874A1 | Polymeric Nanoparticles And A Process Of Preparation Thereof |
| US20220175688A1 | Polymeric Nanoparticles |
| US20200046648A1 | Polymeric Nanoparticles Comprising Salinomycin |
| EP4171543A2 | Nanoparticles And Methods Of Manufacture Thereof |
| EP3714257A4 | Polymeric Nanoparticles Comprising Bortezomib |
| EP3823589A1 | Polymeric Nanoparticles Comprising Salinomycin |
| CN113164375A | Polymeric Nanoparticles Comprising Salinomycin |
| CN111373246A | Polymeric Nanoparticles Comprising Bortezomib |
| WO2023034605A1 | Polymeric Nanoparticles Comprising A Histone Deacetylase 6 / Phosphoinositide 3-Kinase-8 Dual Inhibitor And Related Methods |
| WO2022251844A1 | Polymeric Nanoparticles Comprising Chemotherapeutic Compounds And Related Methods |
| WO2022187849A1 | Salinomycin Derivatives And Uses Thereof |
| WO2022178510A1 | Nanoparticles For Use In Treating Viral Infections |
| AU2021300174A1 | Nanoparticles And Methods Of Manufacture Thereof |
| CA3186633A1 | Nanoparticles And Methods Of Manufacture Thereof |
| AU2019307629A1 | Polymeric Nanoparticles Comprising Salinomycin |
| CA3105731A1 | Polymeric Nanoparticles Comprising Salinomycin |
| CA3079751A1 | Polymeric Nanoparticles Comprising Bortezomib |
| HK40045678A | Polymeric Nanoparticles Comprising Salinomycin |
| HK40038621A | Polymeric Nanoparticles Comprising Bortezomib |
| US20190151340A1 | Polymeric Nanoparticles Comprising Bortezomib |
| WO2022006271A3 | Nanoparticles And Methods Of Manufacture Thereof |
| WO2019104001A1 | Polymeric Nanoparticles Comprising Bortezomib |
| AU2018372924A1 | Polymeric Nanoparticles Comprising Bortezomib |
What are Hillstream BioPharma key innovation segments?
What Technologies are Covered by Hillstream BioPharma?
The chart below distributes patents filed by Hillstream BioPharma